Show
Sort by
-
- Miscellaneous
- open access
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
-
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies
-
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial
-
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps
-
A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)
(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB132-AB132 -
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
- Journal Article
- A1
- open access
Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy